Study design and implementation
This was a single-center retrospective historical control study to assess whether addition of eltrombopag to IST in SAA could improve the hematological response and long-term efficacy in pediatric patients. This study was approved by the Institutional Review Board of Beijing Children’s Hospital, Capital Medical University. All the patients or their legal guardians provided written informed consent.